ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

A molecular on/off switch for CRISPR – Science Daily

Continue reading

2017-03-29 Michael Zand NEWS

Stem Cell Engineering Gets a Boost with Discovery of “Fine-Tuning Knob” – Genetic Engineering & Biotechnology News (blog)


Science Daily

A molecular on/off switch for CRISPR
Science Daily
For many bacteria, one line of defense against viral infection is a sophisticated RNA-guided “immune system” called CRISPR-Cas. At the center of this system is a surveillance complex that recognizes viral DNA and triggers its destruction. However …

Continue reading

2017-03-29 Michael Zand NEWS

How to Indirectly Invest in Synthetic Genomics Stock – Nanalyze


Genetic Engineering & Biotechnology News (blog)

Stem Cell Engineering Gets a Boost with Discovery of “Fine-Tuning Knob”
Genetic Engineering & Biotechnology News (blog)
Researchers at the University of California San Diego say they have discovered a protein that regulates the switch of embryonic stem cells from the least developed naive state to the more developed primed state. This discovery sheds light on stem cell …

Continue reading

2017-03-29 Michael Zand NEWS

French Gene Therapy Biotech Gets Ready for Phase II/III – Labiotech.eu (blog)


Nanalyze

How to Indirectly Invest in Synthetic Genomics Stock
Nanalyze
Now after you’ve read all the evidence we’ve put forth, is it safe to say that at this point in time you would say to yourself, “if I had to pick a possible winner in synthetic biology I might not do so bad making an investment in Synthetic Genomics …

Continue reading

2017-03-29 Michael Zand NEWS

French Gene Therapy Biotech Gets Ready for Phase II/III – Labiotech.eu (blog)

French Gene Therapy Biotech Gets Ready for Phase II/III
Labiotech.eu (blog)
Lysogene has crunched the numbers on its observational study for Sanfillipo A – now the company can move into the final phase for its Sanfilippo A therapy. Lysogene is a French biotech specializing in gene therapy of rare CNS diseases. Its lead asset …

and more »

Continue reading

2017-03-29 Michael Zand NEWS

Stem cell transplants offer hope for sufferers of gut disorders – Medical Xpress

French Gene Therapy Biotech Gets Ready for Phase II/III
Labiotech.eu (blog)
Lysogene has crunched the numbers on its observational study for Sanfillipo A – now the company can move into the final phase for its Sanfilippo A therapy. Lysogene is a French biotech specializing in gene therapy of rare CNS diseases. Its lead asset …

Continue reading

2017-03-29 Michael Zand NEWS

Japanese Man Is First to Receive ‘Reprogrammed’ Stem Cells from Another Person – Scientific American


Medical Xpress

Stem cell transplants offer hope for sufferers of gut disorders
Medical Xpress
Professor Young’s lab is exploring the potential for stem cell transplants to treat Hirschsprung’s Disease, and other disorders of the gut’s nervous system. In a recently published article, the team extracted stem cells from healthy parts of the bowel …

Continue reading

2017-03-29 Michael Zand NEWS

Europa widerspricht dem US-Patentamt – Spektrum der Wissenschaft

Europa widerspricht dem US-PatentamtSpektrum der WissenschaftCRISPR-Cpf1 holds the potential for simpler and more precise genome engineering than has been available with CRISPR-Cas9. Feng Zhang and collaborators elucidated the mechanism and harnessed t… Continue reading

2017-03-29 Michael Zand NEWS
  • 1
  • …
  • 1,913
  • 1,914
  • 1,915
  • 1,916
  • 1,917
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Scientific American

Japanese Man Is First to Receive ‘Reprogrammed’ Stem Cells from Another Person
Scientific American
The surgery is expected to set the path for more applications of iPS cell technology, which offers the versatility of embryonic stem cells without the latter’s ethical taint. Banks of iPS cells from diverse donors could make stem cell transplants more …
World first as Japanese team transplants donor iPS cellsAsahi Shimbun

all 7 news articles »